menu
techminis

A naukri.com initiative

google-web-stories
Home

>

Funding News

>

Vishal Meg...
source image

Bloomberg Quint

1M

read

416

img
dot

Image Credit: Bloomberg Quint

Vishal Mega Mart, Sai Life Sciences: Shares Worth Rs 39,000 Crore To Exit Lock-Ins On Tuesday

  • Shares worth over Rs 39,385 crore of Vishal Mega Mart Ltd. and Sai Life Sciences Ltd. are set to exit lock-ins on Tuesday as per Nuvama's report.
  • As much as 56% equity of Vishal Mega Mart and 48% equity of Sai Life Sciences is becoming eligible for trade.
  • 254.2 crore shares of Vishal Mega Mart worth Rs 31,775 crore will be free to trade, almost four times more than the IPO size.
  • Vishal Mega Mart debuted strongly, listing at Rs 104 against the IPO price of Rs 78, now trading around Rs 125 with a 60% return.
  • Sai Life Sciences had a robust post-IPO performance, listing at Rs 764 against the IPO price of Rs 549, currently trading at Rs 763.
  • Analysts' view on Vishal Mega Mart - seven recommend 'Buy', one 'Hold', one 'Sell', with targets ranging from Rs 90 to Rs 161.
  • Sai Life Sciences is tracked by four analysts, two 'Buy', one 'Hold', one 'Sell', with the most bullish target at Rs 911 by Morgan Stanley.
  • Shares worth Rs 31,775 crore of Vishal Mega Mart and Rs 7,610 crore of Sai Life Sciences will become free to trade.
  • Vishal Mega Mart and Sai Life Sciences have impressive investor confidence and performance post-IPO.
  • Vishal Mega Mart's equity value post lock-in period is nearly four times the IPO size, while Sai Life Sciences' value is 2.5 times the IPO size.
  • Vishal Mega Mart stock surged from IPO price of Rs 78 to current Rs 125, representing a 60% return.
  • Sai Life Sciences' stock listed at Rs 764, currently trading at Rs 763, showing investor confidence.
  • Analysts foresee positive outlook for both Vishal Mega Mart and Sai Life Sciences stocks with varied target prices.
  • The news mentions the end of the lock-in period for the shares of Vishal Mega Mart and Sai Life Sciences on Tuesday.
  • Investor interest remains strong in both companies, with Vishal Mega Mart showing a 60% return over the IPO price and Sai Life Sciences remaining 38% above its issue price.

Read Full Article

like

16 Likes

For uninterrupted reading, download the app